Document is current
Any future updates will be listed below
-
Authors
Chen, Pan
Zhao, Yan-Jie
An, Feng-Rong
Li, Xiao-Hong
Lam, Mei Ieng
Lok, Ka-In
Wang, Yue-Ying
Li, Jia-Xin
Su, Zhaohui
Cheung, Teris
Ungvari, Gabor S.
Ng, Chee H.
Zhang, Qinge
Xiang, Yu-Tao
-
Funding
Funding for this research was provided by:
National Science and Technology Major Project for investigational new drug (2018ZX09201-014)
the Beijing Hospitals Authority Clinical Medicine Development of special funding support (XMLX202128)
Faculdade de Ciências da Saúde, Universidade de Macau (MYRG2019-00066-FHS; MYRG2022-00187-FHS)
- License Information
-
More Information
Article History
Received: 8 June 2023
Accepted: 14 September 2023
First Online: 14 November 2023
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. Approval of the study was granted by the Institutional Review Board of Beijing Anding hospital and respective hospitals. Informed consent was obtained from all subjects.
: Not applicable.
: The authors have no conflicts of interest to declare.
